My research involves development of advanced tissue processing, high-resolution 3D imaging platforms, and computational tools — including machine learning and artificial intelligence — to advance the emerging field of 3D digital pathology. The main idea is that incorporating 3D imaging and AI tools will allow us to comprehensively investigate the complex spatial relationships (eg. the tumor-immune microenvironment) in tissues in comparison to our current standard 2D diagnostic tools (eg. slide-based histology and IHC imaging). By developing these innovative tools, our mission is to enhance the understanding, diagnosis and treatment of diseases.
My lab is deeply committed to collaborative science, working closely with clinical researchers, pathologists, and bioengineers to ensure our discoveries are both scientifically robust and translationally meaningful. We have initiated collaborations with nephrologists developing disease atlases, and cancer researchers and pathologists working on diagnostic imaging. By bridging basic research with clinical application, we strive to accelerate the development of next-generation diagnostic tools and therapeutic strategies that improve patient outcomes.
Post-doctoral Fellowship - University of Washington (Seattle, WA) 2021-2025
PhD - University of Cambridge (Cambridge, UK) 2017-2021
